XML 49 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated statements of comprehensive income - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
 [1]
Dec. 31, 2020
Statement of comprehensive income [abstract]      
Net income € 8,484 € 6,279 € 12,330 [2]
Attributable to equity holders of Sanofi 8,371 6,223 12,294 [3]
Attributable to non-controlling interests 113 56 36 [1],[4]
Other comprehensive income:      
Actuarial gains/(losses) 654 686 (267) [1]
Change in fair value of equity instruments included in financial assets and financial liabilities 13 165 320 [1]
Tax effects (216) (54) (39) [1]
Items not subsequently reclassifiable to profit or loss 451 797 14 [1]
Change in fair value of debt instruments included in financial assets (77) (21) 15 [1]
Change in fair value of cash flow hedges 7 (6) 4 [1]
Change in currency translation differences 2,278 2,459 (3,976) [1]
Tax effects 105 78 (64) [1]
Items subsequently reclassifiable to profit or loss 2,313 2,510 (4,021) [1]
Other comprehensive income for the period, net of taxes 2,764 3,307 (4,007) [1]
Comprehensive income 11,248 9,586 8,323 [1]
Attributable to equity holders of Sanofi 11,130 9,519 8,307 [1]
Attributable to non-controlling interests € 118 € 67 € 16 [1]
[1] Includes the impacts of the IFRIC final agenda decisions of March 2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April 2021 on the attribution of benefits to periods of service, as described in Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021.
[2] Includes the impacts of the IFRIC final agenda decisions of March 2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April 2021 on the attribution of benefits to periods of service, as described in Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021.
[3] Includes the impacts of the IFRIC final agenda decisions of March 2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April 2021 on the attribution of benefits to periods of service, as described in Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021.
[4] (j)    Includes the impacts of the IFRIC final agenda decisions of March 2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April 2021 on the attribution of benefits to periods of service, as described in Note A.2.1. to the consolidated financial statements for the year ended December 31, 2021.